Ligand validation:5E0A

NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose

NAG is a Ligand Of Interest in 5E0A designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
5E0A_NAG_C_201	5%	26%	0.354	0.759	0.7	2.23	-	7	9	0	100%	0.6
3NG4_NAG_C_173	12%	5%	0.177	0.703	1.25	4	2	11	3	0	100%	1
4Q8S_NAG_C_201	9%	62%	0.228	0.722	0.51	0.94	-	1	4	0	100%	1
4Q9E_NAG_C_201	6%	46%	0.275	0.702	0.76	1.3	1	2	0	0	100%	1
3QS0_NAG_B_172	4%	43%	0.363	0.749	0.53	1.66	-	4	0	0	100%	1
4ORV_NAG_C_202	3%	36%	0.286	0.638	0.69	1.8	-	5	2	0	100%	0.9
3H0C_NAG_A_794	100%	56%	0.021	0.995	0.61	1.08	-	1	0	0	100%	0.9333
5LDS_NAG_B_1007	100%	67%	0.022	0.995	0.48	0.79	-	-	0	0	100%	0.9333
5O5D_NAG_B_501	100%	64%	0.02	0.995	0.38	0.97	-	1	0	0	100%	0.9333
6MUG_NAG_G_629	100%	76%	0.022	0.994	0.35	0.58	-	-	0	0	100%	0.9333
3GXM_NAG_A_498	100%	45%	0.026	0.992	0.75	1.34	-	2	0	0	100%	0.9333

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.